Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 15/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 14/20 | 0.49 |
| ▸ | NQO2 | P16083 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8305774 | 0.82 | CHRM1 (0.52) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL14875980 | 0.80 | NOTUM (0.44) | — | |
| SCHEMBL14876545 | 0.78 | PTGDR2 (0.49) | — | |
| SCHEMBL26646898 | 0.77 | BRD4 (0.56) | SMN1; SMN2 | |
| SCHEMBL9854057 | 0.77 | CACNA1S (0.53) | — | |
| SCHEMBL10738495 | 0.73 | NOTUM (0.46) | MTNR1AMTNR1BNQO2SMN1; SMN2 | |
| SCHEMBL10829246 | 0.73 | NOTUM (0.58) | SMN1; SMN2 | |
| SCHEMBL10746029 | 0.73 | BMPR1B (0.41) | SMN1; SMN2 | |
| SCHEMBL578369 | 0.72 | LMNA (0.60) | — | |
| SCHEMBL30068092 | 0.72 | MEN1 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120309823-A1 | PERCUTANEOUS ABSORPTION PREPARATIONS | SUZUKI YASUYUKI (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20090264521-A1 | Percutaneous absorption preparation | SUZUKI YASUYUKI | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264521-A1 | Percutaneous absorption preparation | MTNR1A, MTNR1B, NPSR1 | MTNR1A 1/4885MTNR1B 2/4885NQO2 2145/4885 |
| US-20120309823-A1 | PERCUTANEOUS ABSORPTION PREPARATIONS | MTNR1A, MTNR1B, MC1R | MTNR1A 1/4885MTNR1B 2/4885NQO2 1994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.